Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Arthritis Rheum ; 38(1): 139-41, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7818563

ABSTRACT

A 45-year-old man with severe gout was admitted to the hospital because of Staphylococcus aureus septicemia. He had also a biclonal dysglobulinemia, without signs of myeloma. An asymptomatic lytic lesion of the left pedicle of L5 was discovered on radiographs. Histologic examination of the biopsied lesion showed typical tophaceous gout.


Subject(s)
Gout/complications , Lumbar Vertebrae , Spinal Diseases/complications , Gout/diagnostic imaging , Gout/microbiology , Humans , Lumbar Vertebrae/diagnostic imaging , Male , Middle Aged , Radiography , Spinal Diseases/diagnostic imaging , Spinal Diseases/microbiology , Staphylococcus aureus/isolation & purification
3.
Rev Rhum Mal Osteoartic ; 59(9): 567-70, 1992 Oct.
Article in French | MEDLINE | ID: mdl-1494739

ABSTRACT

A 52-year-old male developed hypertrophy of the right calf after several bouts of right lumbar pain with sciatica. Electromyography disclosed evidence of demyelination in the territories of the right S1 and S2 roots. Microscopic studies showed both atrophic muscle fibers scattered among fibers of normal caliber and a large number of hypertrophic fibers. Post-sciatica hypertrophy of the calf is a true muscle hypertrophy with muscle weakness. Electromyography may show unusual tracings with repeated complex bursts or continuous activity of motor units. Muscle enzyme levels may be elevated. The size of hypertrophied fibers varies across cases. The cause of the muscle fiber hypertrophy may be either stretching due to the action of antagonists or unusual electrical activity.


Subject(s)
Muscles/pathology , Sciatica/complications , Spinal Nerve Roots , Electromyography , Humans , Hypertrophy/complications , Hypertrophy/physiopathology , Male , Middle Aged , Muscles/physiopathology
4.
Therapie ; 45(5): 419-22, 1990.
Article in French | MEDLINE | ID: mdl-2260035

ABSTRACT

Two new cases of osteofluorosis are presented. They are attested by the existence of a bone X-ray densification, by histological lesions of hyperosteoidosis and a large increase in the fluorine content. One is a 61 year-old man who consumed 2.5 l a day of Vichy St-Yorre (a mineral water containing 8 mg of fluorine ions per litre) during 11 years; the other, an 86 year-old man who during 20 years took 500 mg of niflumic acid a day, a non-steroidal anti-inflammatory drug containing 3 fluorine atoms per molecule (i.e., 50 mg fluorine per 250 mg gellule). Both these hypertensive patients had severe renal insufficiency. These two observations serve as a reminder of the indispensable precautions to be observed when prescribing fluorine salts in the treatment of post-menopausal osteoporosis: at least the plasma creatinine level should be available in order to calculate the endogenous creatinine clearance and any possible supplementary intake of fluorine salts should be checked.


Subject(s)
Bone Diseases/chemically induced , Fluorine/poisoning , Aged , Aged, 80 and over , Humans , Iatrogenic Disease , Kidney Failure, Chronic/complications , Male , Mineral Waters/adverse effects , Niflumic Acid/adverse effects , Risk Factors
9.
Pathol Biol (Paris) ; 38(1): 53-6, 1990 Jan.
Article in French | MEDLINE | ID: mdl-1689813

ABSTRACT

Neuropeptides, among which substance P, VIP (Vasoactive intestinal peptide), somatostatin, neurotensin, dynorphin and enkephalins, are able to modulate inflammatory processes. Increasing interest is now devoted to these peptides in different inflammatory diseases, concerning skin, lung and joins. The effect of substance P can be dependent on its C-terminal moiety implicating by this way an interaction with specific neurokinin receptors or can be dependent on its N-terminal moiety which does not involve a specific membrane receptor. Such diversity of the action mechanisms of peptides should influence the evolution of the anti-inflammatory therapeutic.


Subject(s)
Inflammation/physiopathology , Neuropeptides/physiology , Arthritis/physiopathology , Humans , Mast Cells/physiology , Membrane Proteins/physiology , Substance P/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...